These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1861937)
1. Scoliosis in beta thalassemia. Papageorgiou O; Papanastasiou DA; Beratis NG; Korovessis P; Oikonomopoulos A Pediatrics; 1991 Aug; 88(2):341-5. PubMed ID: 1861937 [No Abstract] [Full Text] [Related]
2. Medical management of beta-thalassemia. Lerner N Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747 [No Abstract] [Full Text] [Related]
3. [Our experience with "supertransfusive" treatment of homozygous beta-thalassemia]. Esposito L; Ferrara M; Ponte G Pediatria (Napoli); 1983; 91(1):27-30. PubMed ID: 6889088 [No Abstract] [Full Text] [Related]
4. The management of the improved prognosis in thalassemia major. Modell B Birth Defects Orig Artic Ser; 1982; 18(7):329-37. PubMed ID: 6819016 [No Abstract] [Full Text] [Related]
5. [Chelating therapy in beta-thalassemia]. Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040 [TBL] [Abstract][Full Text] [Related]
6. Growth and sexual maturation in thalassemia major. Borgna-Pignatti C; De Stefano P; Zonta L; Vullo C; De Sanctis V; Melevendi C; Naselli A; Masera G; Terzoli S; Gabutti V J Pediatr; 1985 Jan; 106(1):150-5. PubMed ID: 3965675 [TBL] [Abstract][Full Text] [Related]
7. The clinical management of homozygous beta-thalassemia. Cividalli G Haematologica; 1979 Feb; 64(1):1-12. PubMed ID: 109360 [No Abstract] [Full Text] [Related]
11. Reduction of iron overload in thalassemia. Piomelli S; Graziano J Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742 [No Abstract] [Full Text] [Related]
12. [Effect of hematologic treatment on the growth and puberty of children with thalassemia major]. Pomarède R; Girot R; Constant S; Rappaport R Arch Fr Pediatr; 1984 Apr; 41(4):255-9. PubMed ID: 6477042 [TBL] [Abstract][Full Text] [Related]
13. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Borgna-Pignatti C; Rugolotto S; De Stefano P; Zhao H; Cappellini MD; Del Vecchio GC; Romeo MA; Forni GL; Gamberini MR; Ghilardi R; Piga A; Cnaan A Haematologica; 2004 Oct; 89(10):1187-93. PubMed ID: 15477202 [TBL] [Abstract][Full Text] [Related]
14. [Thalassemia major: chelating therapy with deferoxamine]. Abreu de Miani MS; Sanchis de Herrlein MS; Peñalver JA Medicina (B Aires); 1985; 45(3):231-4. PubMed ID: 3841934 [No Abstract] [Full Text] [Related]